Form 8-K KEMPHARM, INC For: Nov 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities rebound to close higher as surging Treasury yields recede
- Fed’s Jefferson sees no urgency for another rate increase
- Oil jumps 4% on reports China halts fuel exports, US troops head to Middle East
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
KemPharm (KMPH) Misses Q3 EPS by 26c
November 12, 2015 4:45 PM ESTKemPharm (NASDAQ: KMPH) reported Q3 EPS of ($0.68), $0.26 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on KemPharm (KMPH) click here.
... More